Treating Women who are Pregnant and Parenting for OUD - Lit Review
This article summarizes the literature review conducted to obtain current evidence on treatment approaches for pregnant and parenting women with OUD and their infants and children.
Methadone, Buprenorphine, and Naltrexone for the Treatment of OUD in Pregnant Women
Pregnant women with opioid use disorder can be treated with methadone, buprenorphine, or naltrexone to reduce opioid use and improve retention to treatment. In this review, we compare the pregnancy outcomes of methadone, buprenorphine, and naltrexone in clinical trials and discuss the potential behavioral and developmental effects of these agents seen in offspring in animal studies.
Treating Women with Opioid Use Disorder during Pregnancy in Appalachia
This is a retrospective chart review of 26 mother infant dyads in comprehensive medication-assisted treatment with buprenorphine and naloxone during pregnancy
Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
A retrospective cohort study was conducted of 855 mother infant dyads between 1 July 2013 and 30 June 2015. Cases included all women who had exposure to buprenorphine+naloxone during pregnancy.
Buprenorphine and Naloxone Compared With Methadone Treatment in Pregnancy
Objective was to compare neonatal abstinence syndrome prevalence and characteristics among neonates born to women prescribed buprenorphine and naloxone compared with methadone during pregnancy
ACOG Opinion - Opioid Use Disorder in Pregnancy
The American College of Obstetricians and Gynecologists recommendations adn conclusions on opioid use and opioid use disorder during pregnancy.